Chongqing, China

Jun Chen

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Chongqing Precision Biotech Co., Ltd.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Chen. Retrieved from https://idiyas.com/inventor/jun-chen-v6f6jrw7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jun Chen: Innovator in Biotech Solutions

Introduction

Jun Chen is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions that enhance the efficacy of CAR-T cell therapies. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.

Latest Patents

Jun Chen's latest patents include an improved hinge area and its application in constructing CAR skeletons. This invention provides an enhanced hinge area that can prolong the survival of CAR-T cells in vivo and improve their capability to infiltrate tumors. Additionally, he has developed a record protector sleeve, which showcases his versatility in addressing various challenges in biotechnology.

Career Highlights

Jun Chen is currently associated with Chongqing Precision Biotech Co., Ltd., where he continues to innovate and contribute to the field. His work is characterized by a commitment to improving therapeutic outcomes for patients through advanced biotechnological solutions.

Collaborations

Jun Chen collaborates with talented individuals such as Wei Zhang and Juanjuan Shan, who contribute to the dynamic environment of innovation at Chongqing Precision Biotech Co., Ltd.

Conclusion

Jun Chen's contributions to biotechnology, particularly in CAR-T cell therapies, highlight his role as a key innovator in the field. His patents reflect a dedication to improving cancer treatment and enhancing patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…